These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7962680)

  • 1. Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine.
    Ackerman DL; Greenland S; Bystritsky A; Morgenstern H; Katz RJ
    J Clin Psychopharmacol; 1994 Aug; 14(4):247-54. PubMed ID: 7962680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A predictive study of obsessive-compulsive disorder response to clomipramine.
    Alarcon RD; Libb JW; Spitler D
    J Clin Psychopharmacol; 1993 Jun; 13(3):210-3. PubMed ID: 8354737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.
    DeVeaugh-Geiss J; Katz R; Landau P; Goodman W; Rasmussen S
    Psychopharmacol Bull; 1990; 26(1):54-9. PubMed ID: 2196627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of drug treatment response in obsessive-compulsive disorder.
    Ravizza L; Barzega G; Bellino S; Bogetto F; Maina G
    J Clin Psychiatry; 1995 Aug; 56(8):368-73. PubMed ID: 7635854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features associated with treatment response in obsessive-compulsive disorder.
    Shavitt RG; Belotto C; Curi M; Hounie AG; Rosário-Campos MC; Diniz JB; Ferrão YA; Pato MT; Miguel EC
    Compr Psychiatry; 2006; 47(4):276-81. PubMed ID: 16769302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels.
    Mavissakalian MR; Jones B; Olson S; Perel JM
    J Clin Psychopharmacol; 1990 Aug; 10(4):261-8. PubMed ID: 2286699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of obsessive-compulsive neurosis with clomipramine (Anafranil).
    Ananth J
    J Int Med Res; 1977; 5 Suppl 5():38-41. PubMed ID: 598604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress and therapeutic response in the obsessive-compulsive disorder].
    Chinchilla Moreno A; Padín Calo JJ; Vega Piñero M; Llinares Zaragoza C; Fabregat Navarro V; Díaz Marsa M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(1):9-19. PubMed ID: 7717153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder.
    Mavissakalian M; Jones B; Olson S; Perel JM
    Psychopharmacol Bull; 1990; 26(1):119-22. PubMed ID: 2371366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment.
    Stewart SE; Yen CH; Stack DE; Jenike MA
    J Psychiatr Res; 2006 Sep; 40(6):511-9. PubMed ID: 16229857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis.
    Stern RS; Marks IM; Wright J; Luscombe DK
    Postgrad Med J; 1980; 56 Suppl 1():134-9. PubMed ID: 7393824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obsessions and compulsions across time in 79 children and adolescents with obsessive-compulsive disorder.
    Rettew DC; Swedo SE; Leonard HL; Lenane MC; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1050-6. PubMed ID: 1429404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clomipramine (Anafranil) in depressive patients with obsessive neurosis.
    Singh AN; Sexena B; Gent M
    J Int Med Res; 1977; 5 Suppl 5():25-32. PubMed ID: 598603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder.
    DeVeaugh-Geiss J; Landau P; Katz R
    Psychopharmacol Bull; 1989; 25(1):36-40. PubMed ID: 2672070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A control study of clomipramine and amitriptyline for treating obsessive-compulsive disorder].
    Zhao JP
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Apr; 24(2):68-70, 123. PubMed ID: 1860383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worldwide use of clomipramine.
    Trimble MR
    J Clin Psychiatry; 1990 Aug; 51 Suppl():51-4; discussion 55-8. PubMed ID: 2199435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
    Hoehn-Saric R; McLeod DR; Zimmerli WD; Hipsley PA
    J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of clomipramine hydrochloride (Anafranil) and behaviour therapy in the treatment of obsessive neurosis.
    Solyom L; Sookman D
    J Int Med Res; 1977; 5 Suppl 5():49-61. PubMed ID: 598605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.